» start page / index

 » ECP 2007

 » Cytology 2008

 » IAP seminars

 » University of Helsinki
    weekly seminars

 » Tampere University
    Hospital seminars

 » various seminars

 » search

Clinicopathological Congress August 27, 2009
Nordic Society of Nephrology
30th Anniversary Congress

 
Case 1a  
Case 1b  
Case 1 EM  
Case 1: Dr. Ole Wirta and Dr. Anne Räisänen-Sokolowski
Female, 35 years.
Clinical Fabry's disease. Marginal albuminuria, otherwise no signs or symptoms of renal disease. Renal biopsy performed on neurologists request to assess the need for treatment.

Immunofluorescence: Bright mesangial, granular IgA deposits, less intensive IgM and C3 with similar pattern and location.

Electron micrograph: Glomerular podocyte with large electron-dense myelin figures.

Fig 1

  

 Diagnosis & discussion

 
Case 2  
Case 2: Dr. Willy Aasebø and Dr. Erik Heyerdahl Strøm
Male, 53-yrs-old Six years earlier he developed nephritis with SCr 120 and was C-ANCA positive. A renal biopsy showed a focal segmental necrotizing glomerulonephritis consistently with morbus Wegener. He was treated in hemodialysis for four years until he received a kidney transplant.
Two years and 11 months later he developed increasing dyspnea, edema, anemia, increasing creatinine and eventually fever. A graft biopsy was performed.

  

 Diagnosis & discussion

 
Case 3a  
Case 3b  
Case 3c  
Case 3d  
Case 3: Dr. Hans Dieperink and Dr. Niels Marcussen
36-years old male, Native kidney disease membranoproliferative glomerulonephritis, LRD kidney, First Tx. A total of 6 biopsies during 4 months. Graftectomy 4 months after Tx.
Graft biopsy #3a is performed 38 days post-tx due to increased s-creatinine (293 micromol/l) Graft biopsy #3b is performed 61 days post-tx, s-creatinine 560.
Graft biopsy #3c is performed 108 days post tx. Pt. in dialysis.
Graftectomy specimen #3d months post-tx.

Fig 1 Fig 2 Fig 3 Fig 4 Fig 5 Fig 6

  

 Diagnosis & discussion


All material on this website is protected by copyright. By accessing or downloading contents
from this website, you expressly agree and consent to our terms and conditions.